annual FCF:
$7.28B+$708.00M(+10.78%)Summary
- As of today (April 13, 2025), AZN annual free cash flow is $7.28 billion, with the most recent change of +$708.00 million (+10.78%) on December 31, 2024.
- During the last 3 years, AZN annual FCF has risen by +$3.51 billion (+93.33%).
- AZN annual FCF is now -28.35% below its all-time high of $10.15 billion, reached on December 31, 2009.
Performance
AZN Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$1.95B-$73.00M(-3.60%)Summary
- As of today (April 13, 2025), AZN quarterly free cash flow is $1.95 billion, with the most recent change of -$73.00 million (-3.60%) on December 31, 2024.
- Over the past year, AZN quarterly FCF has stayed the same.
- AZN quarterly FCF is now -44.16% below its all-time high of $3.50 billion, reached on December 31, 2009.
Performance
AZN quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$7.28B+$518.00M(+7.67%)Summary
- As of today (April 13, 2025), AZN TTM free cash flow is $7.28 billion, with the most recent change of +$518.00 million (+7.67%) on December 31, 2024.
- Over the past year, AZN TTM FCF has stayed the same.
- AZN TTM FCF is now -28.35% below its all-time high of $10.15 billion, reached on December 31, 2009.
Performance
AZN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
AZN Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.8% | 0.0% | 0.0% |
| 3 y3 years | +93.3% | +176.9% | +36.4% |
| 5 y5 years | +1329.3% | +176.9% | +36.4% |
AZN Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +93.3% | -32.0% | +176.9% | at high | +40.8% |
| 5 y | 5-year | at high | +1329.3% | -32.0% | +923.6% | at high | +412.7% |
| alltime | all time | -28.4% | +3733.8% | -44.2% | +179.8% | -28.4% | +866.9% |
AstraZeneca Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $7.28B(+10.8%) | $1.95B(-3.6%) | $7.28B(+7.7%) |
| Sep 2024 | - | $2.02B(-16.2%) | $6.76B(-3.0%) |
| Jun 2024 | - | $2.42B(+174.3%) | $6.97B(+20.4%) |
| Mar 2024 | - | $881.00M(-38.6%) | $5.79B(-11.9%) |
| Dec 2023 | $6.57B(-9.3%) | $1.43B(-35.8%) | $6.57B(-5.9%) |
| Sep 2023 | - | $2.23B(+81.0%) | $6.98B(+6.3%) |
| Jun 2023 | - | $1.24B(-25.7%) | $6.56B(+8.8%) |
| Mar 2023 | - | $1.66B(-9.8%) | $6.03B(-16.7%) |
| Dec 2022 | $7.24B(+92.3%) | $1.84B(+1.4%) | $7.24B(+18.8%) |
| Sep 2022 | - | $1.82B(+158.0%) | $6.09B(+14.3%) |
| Jun 2022 | - | $705.00M(-75.4%) | $5.33B(+3.2%) |
| Mar 2022 | - | $2.87B(+309.9%) | $5.17B(+37.3%) |
| Dec 2021 | $3.76B(+71.6%) | $700.00M(-33.9%) | $3.76B(-12.8%) |
| Sep 2021 | - | $1.06B(+96.5%) | $4.31B(-1.3%) |
| Jun 2021 | - | $539.00M(-63.2%) | $4.37B(+12.2%) |
| Mar 2021 | - | $1.47B(+17.2%) | $3.90B(+77.6%) |
| Dec 2020 | $2.19B(+330.8%) | $1.25B(+11.9%) | $2.19B(+13.5%) |
| Sep 2020 | - | $1.12B(+1673.0%) | $1.93B(+22.5%) |
| Jun 2020 | - | $63.00M(-126.6%) | $1.58B(+11.2%) |
| Mar 2020 | - | -$237.00M(-123.9%) | $1.42B(+178.8%) |
| Dec 2019 | $509.00M(-59.2%) | $990.00M(+29.9%) | $509.00M(-61.8%) |
| Sep 2019 | - | $762.00M(-893.8%) | $1.33B(+72.8%) |
| Jun 2019 | - | -$96.00M(-91.6%) | $772.00M(+34.5%) |
| Mar 2019 | - | -$1.15B(-163.2%) | $574.00M(-54.0%) |
| Dec 2018 | $1.25B(-36.3%) | $1.81B(+807.5%) | $1.25B(-1122.1%) |
| Sep 2018 | - | $200.00M(-168.0%) | -$122.00M(-107.8%) |
| Jun 2018 | - | -$294.00M(-38.0%) | $1.57B(-12.0%) |
| Mar 2018 | - | -$474.00M(-206.3%) | $1.78B(-9.0%) |
| Dec 2017 | $1.96B(+6.9%) | $446.00M(-76.4%) | $1.96B(-30.8%) |
| Sep 2017 | - | $1.89B(-2433.3%) | $2.83B(+104.3%) |
| Jun 2017 | - | -$81.00M(-72.7%) | $1.39B(+114.2%) |
| Mar 2017 | - | -$297.00M(-122.5%) | $647.00M(-64.7%) |
| Dec 2016 | $1.83B(+241.6%) | $1.32B(+196.4%) | $1.83B(+234.1%) |
| Sep 2016 | - | $445.00M(-154.3%) | $548.00M(-58.3%) |
| Jun 2016 | - | -$820.00M(-192.4%) | $1.31B(-48.9%) |
| Mar 2016 | - | $887.00M(+2363.9%) | $2.57B(+379.5%) |
| Dec 2015 | $536.00M(-87.6%) | $36.00M(-97.0%) | $536.00M(-71.4%) |
| Sep 2015 | - | $1.21B(+177.8%) | $1.87B(-14.7%) |
| Jun 2015 | - | $436.00M(-138.0%) | $2.20B(-18.6%) |
| Mar 2015 | - | -$1.15B(-183.5%) | $2.70B(-37.3%) |
| Dec 2014 | $4.31B(-19.4%) | $1.37B(-10.6%) | $4.31B(-6.9%) |
| Sep 2014 | - | $1.53B(+63.5%) | $4.63B(+23.9%) |
| Jun 2014 | - | $939.00M(+104.6%) | $3.73B(-7.0%) |
| Mar 2014 | - | $459.00M(-72.9%) | $4.02B(-24.8%) |
| Dec 2013 | $5.34B(+129.4%) | $1.69B(+162.7%) | $5.34B(-10.0%) |
| Sep 2013 | - | $644.00M(-47.3%) | $5.93B(+96.0%) |
| Jun 2013 | - | $1.22B(-31.5%) | $3.03B(+9.1%) |
| Mar 2013 | - | $1.78B(-21.9%) | $2.77B(+19.1%) |
| Dec 2012 | $2.33B(-64.3%) | $2.28B(-200.9%) | $2.33B(-14.9%) |
| Sep 2012 | - | -$2.26B(-333.3%) | $2.74B(-59.0%) |
| Jun 2012 | - | $970.00M(-27.5%) | $6.68B(+7.0%) |
| Mar 2012 | - | $1.34B(-50.3%) | $6.24B(-4.3%) |
| Dec 2011 | $6.52B | $2.69B(+60.3%) | $6.52B(-5.8%) |
| Sep 2011 | - | $1.68B(+213.8%) | $6.93B(-6.0%) |
| Jun 2011 | - | $535.00M(-67.0%) | $7.37B(-21.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | $1.62B(-47.7%) | $9.38B(+10.4%) |
| Dec 2010 | $8.50B(-16.3%) | $3.09B(+45.6%) | $8.50B(-4.5%) |
| Sep 2010 | - | $2.12B(-16.6%) | $8.90B(+3.0%) |
| Jun 2010 | - | $2.55B(+245.9%) | $8.64B(-3.4%) |
| Mar 2010 | - | $736.00M(-78.9%) | $8.95B(-11.9%) |
| Dec 2009 | $10.15B(+115.9%) | $3.50B(+87.3%) | $10.15B(+13.4%) |
| Sep 2009 | - | $1.87B(-34.4%) | $8.96B(+6.0%) |
| Jun 2009 | - | $2.85B(+46.5%) | $8.45B(+17.4%) |
| Mar 2009 | - | $1.94B(-15.4%) | $7.19B(+52.9%) |
| Dec 2008 | $4.70B(-19.3%) | $2.30B(+69.2%) | $4.70B(-4.6%) |
| Sep 2008 | - | $1.36B(-14.8%) | $4.93B(+10.9%) |
| Jun 2008 | - | $1.59B(-391.4%) | $4.45B(+27.0%) |
| Mar 2008 | - | -$547.00M(-121.6%) | $3.50B(-39.9%) |
| Dec 2007 | $5.83B(-8.2%) | $2.53B(+188.8%) | $5.83B(+12.6%) |
| Sep 2007 | - | $875.00M(+35.2%) | $5.18B(-14.6%) |
| Jun 2007 | - | $647.00M(-63.7%) | $6.07B(-10.9%) |
| Mar 2007 | - | $1.78B(-5.0%) | $6.80B(+7.1%) |
| Dec 2006 | $6.35B(+7.1%) | $1.88B(+6.4%) | $6.35B(+0.5%) |
| Sep 2006 | - | $1.76B(+27.1%) | $6.32B(+6.3%) |
| Jun 2006 | - | $1.39B(+4.1%) | $5.95B(-0.7%) |
| Mar 2006 | - | $1.33B(-27.7%) | $5.99B(+0.9%) |
| Dec 2005 | $5.93B(+58.0%) | $1.84B(+32.9%) | $5.93B(+0.9%) |
| Sep 2005 | - | $1.39B(-2.9%) | $5.88B(+9.7%) |
| Jun 2005 | - | $1.43B(+11.8%) | $5.36B(+42.6%) |
| Mar 2005 | - | $1.28B(-28.6%) | $3.76B(+0.1%) |
| Dec 2004 | $3.75B(+80.0%) | $1.79B(+106.5%) | $3.75B(+313.9%) |
| Sep 2004 | - | $866.00M(-603.5%) | $907.00M(-48.6%) |
| Jun 2004 | - | -$172.00M(-113.5%) | $1.76B(-19.6%) |
| Mar 2004 | - | $1.27B(-220.1%) | $2.19B(+5.2%) |
| Dec 2003 | $2.09B(-40.3%) | -$1.06B(-161.5%) | $2.09B(-19.3%) |
| Sep 2003 | - | $1.72B(+564.8%) | $2.59B(-9.8%) |
| Jun 2003 | - | $259.04M(-77.7%) | $2.87B(-7.5%) |
| Mar 2003 | - | $1.16B(-308.2%) | $3.10B(-11.3%) |
| Dec 2002 | $3.49B(+100.6%) | -$559.08M(-127.9%) | $3.49B(-18.7%) |
| Sep 2002 | - | $2.00B(+308.6%) | $4.29B(+52.1%) |
| Jun 2002 | - | $490.00M(-68.6%) | $2.82B(+17.6%) |
| Mar 2002 | - | $1.56B(+544.6%) | $2.40B(+38.0%) |
| Dec 2001 | $1.74B(+98.9%) | $242.00M(-54.5%) | $1.74B(-283.5%) |
| Sep 2001 | - | $532.00M(+683.2%) | -$948.66M(-181.3%) |
| Jun 2001 | - | $67.92M(-92.4%) | $1.17B(-28.0%) |
| Mar 2001 | - | $899.08M(-136.7%) | $1.62B(+85.0%) |
| Dec 2000 | $875.25M(+37.8%) | -$2.45B(-192.5%) | $875.25M(-73.7%) |
| Sep 2000 | - | $2.65B(+407.7%) | $3.32B(+391.5%) |
| Jun 2000 | - | $521.29M(+236.8%) | $676.09M(+336.8%) |
| Mar 2000 | - | $154.80M | $154.80M |
| Dec 1999 | $635.00M(-68.7%) | - | - |
| Dec 1998 | $2.03B(<-9900.0%) | - | - |
| Dec 1997 | -$8.27M(-105.5%) | - | - |
| Dec 1996 | $148.99M(-3.6%) | - | - |
| Dec 1995 | $154.52M(+16.3%) | - | - |
| Dec 1994 | $132.89M(-45.2%) | - | - |
| Dec 1993 | $242.59M(-221.2%) | - | - |
| Dec 1992 | -$200.20M(-267.2%) | - | - |
| Dec 1991 | $119.76M(-55.0%) | - | - |
| Dec 1990 | $266.19M | - | - |
FAQ
- What is AstraZeneca annual free cash flow?
- What is the all time high annual FCF for AstraZeneca?
- What is AstraZeneca annual FCF year-on-year change?
- What is AstraZeneca quarterly free cash flow?
- What is the all time high quarterly FCF for AstraZeneca?
- What is AstraZeneca quarterly FCF year-on-year change?
- What is AstraZeneca TTM free cash flow?
- What is the all time high TTM FCF for AstraZeneca?
- What is AstraZeneca TTM FCF year-on-year change?
What is AstraZeneca annual free cash flow?
The current annual FCF of AZN is $7.28B
What is the all time high annual FCF for AstraZeneca?
AstraZeneca all-time high annual free cash flow is $10.15B
What is AstraZeneca annual FCF year-on-year change?
Over the past year, AZN annual free cash flow has changed by +$708.00M (+10.78%)
What is AstraZeneca quarterly free cash flow?
The current quarterly FCF of AZN is $1.95B
What is the all time high quarterly FCF for AstraZeneca?
AstraZeneca all-time high quarterly free cash flow is $3.50B
What is AstraZeneca quarterly FCF year-on-year change?
Over the past year, AZN quarterly free cash flow has changed by $0.00 (0.00%)
What is AstraZeneca TTM free cash flow?
The current TTM FCF of AZN is $7.28B
What is the all time high TTM FCF for AstraZeneca?
AstraZeneca all-time high TTM free cash flow is $10.15B
What is AstraZeneca TTM FCF year-on-year change?
Over the past year, AZN TTM free cash flow has changed by $0.00 (0.00%)